These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers. Robertson P, Hellriegel ET, Arora S, Nelson M. Clin Pharmacol Ther; 2002 Jan; 71(1):46-56. PubMed ID: 11823757 [Abstract] [Full Text] [Related]
3. Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam. Sugimoto K, Araki N, Ohmori M, Harada K, Cui Y, Tsuruoka S, Kawaguchi A, Fujimura A. Eur J Clin Pharmacol; 2006 Mar; 62(3):209-15. PubMed ID: 16416305 [Abstract] [Full Text] [Related]
4. Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam. Barbhaiya RH, Shukla UA, Kroboth PD, Greene DS. J Clin Psychopharmacol; 1995 Oct; 15(5):320-6. PubMed ID: 8830062 [Abstract] [Full Text] [Related]
9. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes. Walzer M, Bekersky I, Blum RA, Tolbert D. Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635 [Abstract] [Full Text] [Related]
11. Lack of effect of a single dose of ketoconazole on the pharmacokinetics of citalopram. Gutierrez M, Abramowitz W. Pharmacotherapy; 2001 Feb; 21(2):163-8. PubMed ID: 11213852 [Abstract] [Full Text] [Related]
16. Triazolam substrate inhibition: evidence of competition for heme-bound reactive oxygen within the CYP3A4 active site. Schrag ML, Wienkers LC. Drug Metab Dispos; 2001 Jan; 29(1):70-5. PubMed ID: 11124232 [Abstract] [Full Text] [Related]
17. Effects of dosing interval on the pharmacokinetic and pharmacodynamic interactions between the oral adsorbent AST-120 and triazolam in humans. Kotegawa T, Tsutsumi K, Morita H, Imai H, Morita M, Yoshizato T, Ohyama T, Uchida S, Watanabe H, Namiki N, Ohashi K. Eur J Clin Pharmacol; 2012 Dec; 68(12):1605-10. PubMed ID: 22644342 [Abstract] [Full Text] [Related]
18. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences. Greenblatt DJ, von Moltke LL, Harmatz JS, Counihan M, Graf JA, Durol AL, Mertzanis P, Duan SX, Wright CE, Shader RI. Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151 [Abstract] [Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine. Hall J, Naranjo CA, Sproule BA, Herrmann N. J Clin Psychopharmacol; 2003 Aug; 23(4):349-57. PubMed ID: 12920410 [Abstract] [Full Text] [Related]
20. Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism. Varhe A, Olkkola KT, Neuvonen PJ. Br J Clin Pharmacol; 1996 Apr; 41(4):319-23. PubMed ID: 8730978 [Abstract] [Full Text] [Related] Page: [Next] [New Search]